Download Technology Capabilities
Advanced deep learning techniques trained on publicly available trial data and real-world events that are continuously crawled, aggregated, and analyzed by Innoplexus’ proprietary technology.
A neural network trained on various drug compound characteristics, clinical trial features, and sponsor track records, provides insights for optimizing study designs.
Fully automated, continuous, and real time analysis enables Innoplexus to calculate predictions by accounting for new information which might impact a trial endpoint.
There are a lot of statistics about drug development – and all of them show that the process is inefficient and expensive:
However, clinical trial failures can be modeled by applying Artificial Intelligence techniques on real-world, outside-trial, and biomedical data sets. Innoplexus’ Clinical Trial Prediction engine leverages advanced deep learning techniques trained on publicly available trial data as well as on real-world events that are continuously crawled, aggregated, and analyzed by our proprietary technology.
CTP helps CROs, pharma, and biotech companies to track clinical trial KPIs, optimize their clinical trial recruitment strategies, and mitigate operational and financial risks. CTP empowers companies to make the decisions and course corrections before obstacles delay a trial.
A pharma or biotech company’s stock performance depends heavily on the outcome of its pipeline. Prior knowledge of approval probability of a trial can help investors gain an edge!
Over the last few years the number and volume of M&A transactions in the pharma industry increased.
CTP supports consulting firms to guide their clients through M&A decisions.
Theses & Dissertation